Do not reuse needles or share your basaglar prefilled pen with other people.
Basaglar pen side effects.
Fluid retention in the legs feet arms or hands.
Along with its needed effects insulin glargine the active ingredient contained in basaglar may cause some unwanted effects.
Reactions at the.
What are side effects of basaglar.
Redness or swelling where an injection was given itchy skin rash over the entire body trouble breathing fast heartbeats feeling like you might pass out or swelling in your tongue or throat.
This can happen even if you change the needle.
Allergic reactions like skin rash itching or hives swelling of the face lips or tongue.
Common side effects of basaglar include.
A stuffy and runny nose.
Do not take basaglar if you have.
Check with your doctor immediately if any of the following side effects occur while taking insulin glargine.
Low blood sugar hypoglycemia allergic reactions.
You or the other person can get a serious infection.
Symptoms of high blood sugar hyperglycemia include thirst increased urination confusion drowsiness flushing rapid breathing and fruity breath odor.
If experienced these tend to have a less severe expression.
Symptoms of low blood sugar hypoglycemia an allergy to basaglar or any of its ingredients.
Side effects to watch for side effects that you should report to your doctor or health care professional as soon as possible.
If these symptoms occur tell your.
Call your doctor for medical advice about side effects.
Thickening or hollowing of the skin where you injected the medicine.
Basaglar insulin glargine injection is a long acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.
Although not all of these side effects may occur if they do occur they may need medical attention.
Similar effects on glycohaemoglobin and the incidence of symptomatic hypoglycemia were observed in both treatment groups however fasting plasma glucose decreased more from baseline in the insulin glargine group than in the nph group.
In a clinical study 5 of children with type 1.
There was less severe hypoglycemia in the insulin glargine group as well.